Taiwan FDA registration f9d9d9e6f815ec0c9dc1d9df6383867d

"Apeth" Efinin Lipid Test Set (Unsterilized)

TW: "亞培" 艾菲寧脂質檢驗試劑組 (未滅菌)

Taiwan·Risk Class 1·ABBOTT DIAGNOSTICS TECHNOLOGIES AS·Registered Jun 28, 2016 – Jun 28, 2026Expired

Registration details

Analysis ID: f9d9d9e6f815ec0c9dc1d9df6383867d
Customs Code: DHA09401670903

Company information

Manufacturer: ABBOTT DIAGNOSTICS TECHNOLOGIES AS
Manufacturer Country: Norway
Authorized Representative: Abbott Rapid Diagnostics Health Corp.

Product details

Intended Use: It is limited to the first level of identification of the "Triglyceride Test System (A.1705)", "Lipoprotein Test System (A.1475)" and "Cholesterol (Total) Test System (A.1175)" of the Medical Device Classification and Grading Management Measures.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1475 Lipoprotein Testing System;; A.1705 Triglyceride test system;; A.1175 Cholesterol (Total) Testing System
Import Information: import

Dates and status

Registration Date: Jun 28, 2016
Expiry Date: Jun 28, 2026

About this record

Access comprehensive regulatory information for "Apeth" Efinin Lipid Test Set (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number f9d9d9e6f815ec0c9dc1d9df6383867d and manufactured by ABBOTT DIAGNOSTICS TECHNOLOGIES AS. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.